gip vs glp 1 receptor agonist Agonism Attenuates GLP-1 Receptor Induced Nausea and Emesis in Preclinical Models — Hayes Lab Emerging Role of Dual GLP-1

GLP-1 RAs have demonstrated benefits in coronary artery disease, heart failure, blood pressure, and atrial fibrillation irrespective of type 2 diabetes mellitus status, with new possible applications in peripheral arterial disease

On February 25th, the FDA announced that the GLP-1 drug shortage was over

This study demonstrated that the long-acting GLP-1R agonist, NLY01, has different health benefits in two different mouse models of MS

A recent small study has found that people may be able to maintain their weight loss with fewer GLP-1 injections, but this strategy may not be effective for everyone.

This review aims to summarize current scientific evidence on the pharmacogenetics of the GLP-1 RA /liraglutide/ and the possible implementation in the treatment of T2D.

Overview of diabetes pills with descriptions of their actions, interactions with other medications and which method is best for both Type 1 and Type 2 diabetes.